WOBURN, MA--(Marketwire - June 15, 2012) - Batavia Bioservices, a service provider aiding its
customers in the development of complex biological medicines, has decided
launch a US facility in Woburn, Massachusetts. The company is headquarted
Leiden, The Netherlands.
Menzo Havenga, President and CEO of Batavia, said: "We have been growing
than four hundred percent in the past two years in the Netherlands and to
up with customer demand we have decided to launch a facility in the Boston
area." Christopher Yallop, COO, adds: "We have chosen the greater Boston
due to its importance as a biotech cluster. Positioning ourselves here
to be close to our customers, which we deem extremely important in
time and on budget." Batavia Bioservices provides a one-stop shop from DNA
cloning to Phase I/II clinical manufacturing for all major classes of
biopharmaceuticals, including antibodies, proteins or vaccines.
"Massachusetts leads the world in life sciences thanks to our growth
investing in education, innovation and infrastructure," said Governor Deval
Patrick. "We welcome Batavia Bioservices, and we look forward to working
them to create jobs and opportunities in the Commonwealth."
"We are excited to welcome Batavia Bioservices to the Massachusetts Life
Sciences community," said Susan Windham-Bannister, Ph.D., President & CEO
Massachusetts Life Sciences Center, the agency charged with implementing
Governor Patrick's 10-year, $1 billion Life Sciences Initiative. "Batavia
provides important services to the life sciences industry sectors, and the
company's presence in Massachusetts will contribute to our economy, as well
strengthen our life sciences ecosystem. I am confident that the team at
will find all of the resources and partners they need to thrive in
"Batavia Bioservices opening a lab facility in Woburn is a testament to the
critical role Massachusetts plays in the global life sciences value chain."
Ken Brown, Executive Director of the Massachusetts Office of International
& Investment. "I wish the company much success and look forward to their
presence in the Commonwealth."
The Woburn facility (± 5500 sq feet), located at Cummings Properties'
TradeCenter 128, contains multiple BSL-2 laboratories dedicated to specific
tasks including Molecular Biology, mammalian cell line generation, protein
production, protein purification or assay development. The company has
hired six employees for the new facility, with plans to hire four more by
end of this year. Joan Hilly, Director Cell Sciences, said: "It's great
have been able to quickly staff our facility with experts in their
fields and in fact we have just started executing the first customer
The announcement comes as the state is preparing to host the 2012 BIO
International Convention, being held June 18-21 at the Massachusetts
& Exhibition Center. The Convention provides state and industry leaders an
opportunity to showcase Massachusetts as a great place to do business for
international life sciences companies.
"Batavia's decision to grow in Massachusetts highlights the strength of the
cluster here in the Commonwealth and the capacity for industry stakeholders
work together to get things done," said Robert Coughlin, President & CEO of
MassBio. "We're thrilled to have such a cutting-edge, growing, global
join the Massachusetts supercluster."
"The opening of a facility in Woburn by Batavia Bioservices shows that the
Netherlands Life Sciences industry is continuing to spread its wings," said
Rob de Vos, Consul General of the Netherlands in New York. "In the
Life Sciences clusters located in various bioscience parks that focus on
translational research could develop due to a combination of high quality
(clinical) research, strong public-private collaborations and a stimulating
business climate. Batavia Bioservices is one of many innovative companies
in such a cluster (Bioscience Park in Leiden)."
"It has been a pleasure working with Batavia to meet its specialized
needs," said Dennis Clarke, Cummings Properties' president and CEO. "The
has a very promising future, and will find good company here at TradeCenter
128, where several other international firms have located their U.S.
Batavia Bioservices opens laboratory facility in greater Boston area:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Batavia Bioservices B.V. via Thomson Reuters ONE